Dotmatics Signs Definitive Agreement to be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences

Siemens continues its industrial software purchasing tour by buying the US software company Dotmatics for 5.1 billion dollars. The acquisition is intended to strengthen Siemens' position in the pharmaceutical industry and drive the growth program ‘One Tech Company'.

Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics

Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries. Siemens said the acquisition was "complementary" to its expansion into Life Sciences and would lift its game in a market needing more medication innovation as populations age. "These trends underscore the need for digital transformation, with software spending expected to…

Siemens buys US firm Dotmatics for $5.1 bn in AI software push

Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries.

Siemens to acquire Dotmatics in $5.1 billion deal in Life Science portfolio push

Financing for the deal would be primarily carried by share sales of listed companies, including health care subsidiary Siemens Healthineers, its finance chief Ralf Thomas said in a statement

Dotmatics Signs Definitive Agreement to be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences

Siemens AG will acquire Dotmatics from global software investor Insight Partners for $5.1 billionAcquisition accelerates Dotmatics' mission to connect scientific discovery to delivery, expanding global scale and reachUnlocks new opportunities to combine Dotmatics' R&D software with Siemens' AI-powered Digital Twin…

Siemens Nears Deal to Buy Insight Partners-Backed Dotmatics for About $5 Billion

Siemens AG has agreed to acquire Dotmatics for $5.1 billion as part of a push to provide more artificial intelligence software to life sciences companies.